Member Info for Brighty1

3p is very possible here in just 1 session. We all know that PYC went from 1.3p to 4.2p in one day and then the next day it went to 10p. Many will also know that PYC went as high as 32p intra-day before closing at 17.1p in one day in 2017. A few more contract gains via RNS and we will be back at the 52 week high of 6.60p....

Good luck, Brighty

It's also worth noting that additional buying pressure in the next couple of sessions will be created by LTH's averaging down now that confidence in the business is being restored. The COO has been hired to turn PYC around. We all know the potential here....

Good luck, Brighty

Well ABDX Chairman Chris Hand sold his previous business Cozart to Concateno for £64.4m cash. Therefore, I doubt he would be interested in small beer takeover deals with ABDX, hence the concert party which will actually protect investors (them and us) from a cheeky buyout offer. With my M&A hat on I'd say we are much more likely to see ABDX acquired in the future for much higher than what people are posting on here. e.g. a £100 million takeover would be x 8 of our current share price. That's much more likely imo. This has 100p a share written all over it in the medium term. Plus don't forget that ABDX has already guided that it expects to report revenue for the 2023 financial year 125 per cent higher than 2022. That indicates that ABDX has a vision and plan to grow exponentially....

Good luck, Brighty

Yes and don’t forget that Astra Zeneca earlier this year forked out 1 billion in a deal for KYM Biosciences for a Phase 1 trial and also in 2023 paid $2 Billion by partnering small bio company, Quell Therapeutics. It just goes to show you how much a licencing deal for a Phase 1 trial such as SDC1801/1802 or SRA737 could be worth.

This could be us soon as it is clearly another major step in the right direction today for SAR and its shareholders....

Good luck, Brighty

Kidlington, you were right. Great Due Diligence on this:

* Dr Sargent held a senior management role at global consultancy business Syneos Health Inc (NASDAQ: SYNH), leading large teams of professionals and servicing a variety of clients in the biopharmaceuticals space.

* Among his earlier roles, Dr Sargent has also been Head of Business Development for the UK's National Institute for Health and Care Research (NIHR), leading a team supporting global life science businesses access to funding and research infrastructure in the UK.

PYC is (at last) going places with this appointment...

Good luck, Brighty

36.84% up in to the close. No 1 Top riser today. Could be an interesting few weeks coming up...

Good luck, Brighty

Yes, next week could be another interesting and highly rewarding few days for PYC investors. Some on here will know that historically PYC has gone up from 1.3p to 4.2p in one day and then the next day it went to 10p and as high as 32p intra-day before closing at 17.1p. That sustained rise happened over a 5 day period. If we get a TR1 or more contract win RNS' this will continue to rise. Have a great weekend all PYC investors and here's to more of the same in the coming weeks....

Good luck, Brighty

The PYC investor website is unquestionably showing a new investor, Gary Marshall, is now holding 3.32%. i.e. a TR1 should be in-bound to excite the wider investor community soon. If it is THE pharma man, Gary Marshall, that Kidlington has posted about on here then that would really get tongues wagging. One to watch out for....

Good luck, Brighty

Up to 1.05p just now. Your bounce prediction for today could be on...

Good luck, Brighty

PYC is in re-rate mode following the contract gains. This is hardly a P&D! It's based on several RNS' from the company about new business wins plus market intel about a new investor. It's also a fact that PYC went from 1.3p to 4.2p in one day and then the next day it went to 10p and as high as 32p intra-day before closing at 17.1p. These are facts and why people are optimistic about PYC's chances moving forward. The MCAP is tiny and the 3% buy in by G Marshall also piqued investors interest. Hardly a P&D. These are facts that have been presented to the market & / or are being revealed by investor due dilligence....

Good luck, Brighty

There will also be averaging down from LTH's happening which will likely create additional buying pressure in the next couple of sessions.....If 3p is achieved today or early next week then your bounce to 6p is certainly a real possibility..

Good luck, Brighty

Yes, now that 2p has been achieved then 4p a share becomes a distinct possibility in the next few days. We might even hit your 3p a share prediction today. It's not rocket science!!! We've seen it happen with this share before...

Good luck, Brighty

50% up+ now at 2p and as we know in 2017 PYC went from 1.3p to 4.2p in one day. The next day it went to 10p and as high as 32p intra-day before closing at 17.1p. So, 8p-10p a share is a possibility moving forward.....

Good luck, Brighty

43% up now and as we know PYC has had a history of 5 days of mega gains in 2017 from 1.3p to 4.2p in one day. It then climbed the next day from 5p to 10p. It then climbed the following day from 10p as high as 32p intra-day before closing at 17.1p. As many have said we probably won't see those 32p share prices for a while but 8p-10p a share is a possibility moving forward. i.e. multi-bag opportunities could happen here...

Good luck, Brighty

I agree. The UK / FCA will be embracing the NEO bank model moving forwards without a doubt. It has to when you bear in mind that NEO banking has a global market size of 72.47 Billion (2022) and is forecast to grow to 2168.31 Billion by 2030. i.e. A CAGR of 52.93% until 2030. I'd say that is a pretty compelling investment strategy. It's why I'm invested in GST as in due course the share price could well be 50p+. Next stop is AimStillHigher's 5p a share prediction. It will happen. Right sector, Right time....

Good luck, Brighty

Robert Keith, for those that don't know, is the investor behind Eidos / Lara Croft. He is a serious investor and one to watch having sold his business, Fast Search & Transfer, to Microsoft for $1.2bn. By upping his holding in GFIN today from 12% to 20.7% is no doubt raising quite a few eyes in the City re a possible MBO or bid at a bargain basement price . Fascinating to see how this pans out...

Good luck, Brighty

What we do know from the holdings / TR1's is that Charles Street / Robert Keith have been investing in GFIN since at least May 2021 - so not just a recent attempt to buy in cheap - as the share price when he started acquiring the holdings in GFIN was over 5p. Even with his recent buying at much lower prices taking his holding to over 20% today it would appear that the current average price Charles Street / Robert Keith paid is going to be somewhere over 1p a share, which is x8 of the current share price. Interesting....

Good luck, Brighty

25% up today already....

Good luck, Brighty

When PYC moves it moves. In 2017 PYC had 5 days of huge gains when it announced a relatively small contract win in November 2017. Back then the PYC share price went from 1.3p to 4.2p in one day. It then climbed the next day from 5p to 10p. It then climbed the following day from 10p as high as 32p intra-day before closing at 17.1p. We won't see those 32p share prices for a while but 8p-10p a share is a possibility moving forward. i.e. multi-bag opportunities could happen here...

Good luck, Brighty

Very interesting news today: Robert Keith increases his holding in GFIN to 20.7% from 12%....

Good luck, Brighty